University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Previous  |  1 |  2 |  3 |  4 |  5 |  6 |  7 |  8 |  9 |  ... |  236 |  Next

Title: Salicylate Toxicity Interventions

Category: Toxicology

Keywords: Salicylate toxicity, cerebral glucopenia, sodium bicarbonate, hemodialysis (PubMed Search)

Posted: 5/6/2026 by Kathy Prybys, MD

Bottom Line: Multiple modalities of intervention may be needed to combat various aspects of salicylate toxicity. These include gastric decontamination, fluid hydration, dextrose admiinistration, aggressive serum alkalinization, establishment of normokalemia and hemodialysis. Intubation and chemical restraint should be avoided if possible.

Show Additional Information

Gastric decontamination: is recommended in those with acute toxicity if there are no contraindications (e.g., inability to protect the airway or refractory vomiting) as salicylate GI pill concretions can occur. Activated charcoal, 1 g/kg orally up to 100 g, is recommended. Salicylates can form gastric bezoars and cause delayed peak levels and toxicity.

Fluid resuscitation: should be addressed early in treatment course as patients can be  volume depleted from multiple sources of fluid loss as much as 2-4 liters which worsens toxicity. D5W with 3 amps of sodium bicarbonate is the preferred fluid to treat volume depletion, hypoglycemia, and acidosis.

Dextrose: Hyperglycemia may present early due to increased cortisol levels, but hypoglycemia can follow and is common as oxidative phosphorylation is impaired and even with normal serum glucose levels cerebral glucopenia. A trial of IV dextrose bolus (0.5-1 g/kg) and/or infusion is recommended with mild encephalopathy

Aggressive serum alkalinization: is integral to management. This typically includes a bolus of 1-2 mEq/kg of hypertonic sodium bicarbonate followed by an infusion of isotonic sodium bicarbonate (150 mEq added to 1 L of 5% dextrose in water). Serum pH adjustment to a goal of 7.50-7.55 will decrease the volume of distribution of salicylate: salicylate will shift out of the tissues and into the serum. Urinary alkalinization aimed to achieve a urine pH >7.5 is a secondary goal. Frequent serial salicylate levels and blood gas determinations (2-4 hours) are necessary and should be correlated with clinical manifestations. 

Normokalemia: is important as urinary alkalinization cannot be achieved if hypokalemia is present. Initial supplementation of potassium (40-60 mEq), addition of potassium (40-60 mEq) to the bicarbonate infusion, and additional administrations in response to therapy and level monitoring is recommended.

Hemodialysis: is necessary and lifesaving in cases with severely high serum salicylate concentrations, refractory acidemia or severe electrolyte disturbance, cerebral edema, altered mental status, renal failure, hypoxia from pulmonary edema, standard therapies not producing an adequate response, and specific serum concentrations. Early consultation with nephrology can expedite treatment.

Intubation or any chemical restraint should be avoided: as sedation and paralysis may result in further decrease in pH, due to hypercarbia from hypoventilation. This results in shifting salicylate to it’s uncharged state which can easily pass into tissues, further worsening toxicity and CNS and myocardial dysfunction. Non-invasive ventilation, such as a high-flow nasal cannula, may reduce the work of breathing. If intubation is necessary hyperventilation to reduce CO2 and bolus of intravenous bicarbonate

Show References

Salicylate Toxicity. Palmer B, Clegg D. New Egland Journal of Medicine. 2020;382(26). 2544-2555. DOI: 10.1056/NEJMra2010852

Hospitalizations for acute salicylate intoxication in the United States. Thongprayoon C, Petnak T, Kaewput W, et al. J Clin Med. 2020;9:2638. doi: 10.3390/jcm9082638.

Acute Salicylate Toxicity: A Narrative Review for Emergency Clinicians. Sidlak AM, Spadaro A, et.al, Cureus. 2025 Sep 2;17(9): e91505. doi: 10.7759/cureus.91505

https://www.acmt.net/wp-content/uploads/2022/06/PRS_130313_Management-Priorities-in-Salicylate-Toxicity.pdf



Title: Buprenorphine and rib fractures in older patients

Category: Trauma

Keywords: Rib fractures, geriatric, pain control (PubMed Search)

Posted: 5/3/2026 by Robert Flint, MD (Updated: 5/3/2026)

A retrospective study looking at use of transdermal Buprenorphine in older trauma patients with rib fractures found a good safety profile (less naloxone use) and less overall opioid use however no change in overall length of stay or mortality. Adding this to your multimodal pain strategy in older patients with rib fractures seems like a reasonable plan.

Show References

ournal of the American Geriatrics SocietyEarly View

CLINICAL INVESTIGATION

Transdermal  Buprenorphine For  Pain Management in Older Patients With Multiple Rib Fractures

Iva Neupane, Brian Mikolasko, Charles A. Adams Jr, Joao Filipe Goncalves Monteiro, Nadia Mujahid, Linda Girouard, Jessica Arabi, Ashna Rajan, Audrea Bose, Stephanie Lueckel, Lynn McNicoll, Stefan Gravenstein

First published: 16 April 2026

https://doi.org/10.1111/jgs.70444



Title: Constipation as a function of a geriatric syndrome

Category: Geriatrics

Keywords: Constipation geriatric complex (PubMed Search)

Posted: 5/2/2026 by Robert Flint, MD (Updated: 5/2/2026)

A narrative review of literature involving older patients and constipation found:

“Major contributing factors include physical inactivity, sarcopenia, dehydration, inappropriate defecation posture, and polypharmacy, particularly opioids and anticholinergic agents. Importantly, these factors interact through the brain–gut–microbiota axis, contributing not only to gastrointestinal dysfunction but also to systemic outcomes such as frailty, cognitive decline, and increased healthcare burden, thereby supporting a multidimensional disease framework.”

It isn’t as simple as adding a laxative.

Show References

Mimura S, Morishita A, Kitaoka A, Sasaki K, Tai H, Yano R, Nakahara M, Oura K, Tadokoro T, Fujita K, et al. Constipation in Older Adults: Pathophysiology, Clinical Impact, and Management Strategies. Geriatrics. 2026; 11(2):47. https://doi.org/10.3390/geriatrics11020047



Title: A medicine can beget another medicine. Should it?

Category: Geriatrics

Keywords: Prescribing cascade (PubMed Search)

Posted: 4/30/2026 by Robert Flint, MD (Updated: 4/30/2026)

The article outlines how instead of looking at medications as the cause of symptoms, we often add more medications to treat the medication induced symptoms.  Here is an example of how we get to polypharmacy in older patients  

Show References

Bry?a A, Woro? J, Miedziaszczyk M, Lorkowska-Zawicka B, Bujak-Gi?ycka B, Orzechowski D, Po?etek P, Pa?ys W. Prescribing Cascade as a Therapeutic Error: A Danger for Geriatric Patients with Multimorbidity. Geriatrics. 2026; 11(2):37. https://doi.org/10.3390/geriatrics11020037



Title: Injuries associated with body armor struck by bullets

Category: Trauma

Keywords: Body armor, blunt injury, BABT (PubMed Search)

Posted: 4/26/2026 by Robert Flint, MD (Updated: 7/21/2026)

Body armor/ bullet resistant vests used by law enforcement are designed to stop penetration by handgun rounds. These rounds have less velocity than rifle rounds. When caring for someone who has been shot while wearing body armor, verify no penetration has occurred and then look for blunt injuries such as rib fractures, liver injuries, pneumothorax, cardiac contusion, vertebral injury, etc. Behind Armor Blunt Trauma (BABT) is the technical term for injuries caused by the transfer of kinetic energy that occurs when these vests are struck.

Show References

Injury

Volume 49, Issue 7, July 2018, Pages 1251-1257

A preliminary study into injuries due to non-perforating ballistic impacts into soft body armour over the spine

Author links open overlay panelRosalind M. Jennings a, Chris Malbon b, Fiona Brock a, Stuart Harrisson c, Debra J. Carr b



Title: Chronic Pain after trauma

Category: Trauma

Keywords: trauma, chronic pain, (PubMed Search)

Posted: 4/23/2026 by Robert Flint, MD (Updated: 4/23/2026)

This narrative review of the trauma literature looking at chronic pain after trauma found: 

  1. Chronic pain occurs in 30–70% of trauma survivors, with prevalence varying by injury type. 
  2. Key risk factors include female sex, younger age, pre-existing pain, psychological distress, and social disadvantage. 
  3. Validated prediction models are available for musculoskeletal trauma
  4. Thoracic trauma is under represented in the pain literature, is often underrecognized, and less protocols are available for treatment
  5. Thoracic pain typically occurs through intercostal nerve damage and persistent pain following thoracic injury
  6. The authors suggest “A trauma-specific, biopsychosocial approach is key to reducing chronic pain and improving recovery.”

Show References

Kussé M, Hans G, Saldien V, Wildemeersch D. Chronic pain following major trauma: Prevalence, predictive models, and risk factors across common injury types. Trauma. 2026;0(0). doi:10.1177/14604086251404750



Title: Ambient AI Scribes – The Future of EM?

Category: Administration

Posted: 4/22/2026 by Steve Schenkel, MD, MPP (Updated: 4/22/2026)

Ambient Artificial Intelligence based scribes that create visit notes based on the conversation in the room during patient evaluation may save documentation time and reduce total time in the health record but may not perform as well as human scribes in some circumstances, at least for pediatric patient charts.

Show Additional Information

Two side-by-side reports in the May Annals of Emergency Medicine portray related but slightly different pictures of ambient scribing. 

Preiksaitis et al found that the offer of an ambient AI scribing system led to some adoption more for lower acuity visits. AI use led to shorter notes, shorter electronic health record time, and about one minute less documentation time per chart. Morey et al compared human and AI scribes and found that human scribes were associated with similar note lengths and metrics for adult patients and somewhat higher quality charts in pediatric patients. An associated editorial argues that AI charting may offer a moment of culture change. (I am one of the authors of the editorial.)

Show References

Preiksaitis C, Alvarez A, Winkel M, et al. Ambient Artificial Intelligence Scribe Adoption and Documentation Time in the Emergency Department. Annals of Emergency Medicine, 2026; 87, 569-574.

Morey J, Jones D, Walker L, et al. Ambient Artificial Intelligence Versus Human Scribes in the Emergency Department. Annals of Emergency Medicine, 2025; 87, 561-568.

Schriger D, Schenkel S. Can Ambient Charting Fix Emergency Medicine? Annals of Emergency Medicine, 2026; 87, 575-577.



Title: P:F vs S:F Ratio

Category: Critical Care

Keywords: Oxygenation, ARDS, P:F Ratio, S:F Ratio, Hypoxia, Mechanical Ventilation (PubMed Search)

Posted: 4/21/2026 by Mark Sutherland, MD (Updated: 7/21/2026)

PaO2 to FiO2 (P:F) ratios, are often considered the gold standard in critical care for assessing the degree of oxygen-refractory hypoxia in various pathologies, particularly ARDS.  P:F does have some limitations, including not accounting for the PEEP, but probably the most limiting is that it requires collecting an ABG, which is invasive and not always feasible or a top priority when resuscitating a critically ill hypoxic patient.  On the other hand, SpO2 (pulse ox saturation) is routinely available, and of course the FiO2 should be known, so many have suggested perhaps using an SpO2 to FiO2 (S:F) ratio instead.  But how S:F maps to P:F and how well they correlate is not fully known.  Chaudhuri et al recently conducted a meta-analysis, published in Critical Care Medicine this month, which reviewed the literature on this. 

Bottom Line: Yes, S:F ratios correlate well with P:F ratios, especially when the SpO2 is less than 97%, but you can't just substitute the S:F for P:F, you have to use one of the accepted formulas.  See additional info on the website for the actual formula to apply and how a given S:F translates to P:F.

Show Additional Information

The authors identified 4 particularly high performing formulas from well-done studies.  One was logarithmic, and two were non-linear, making the math hard, so the best is probably the linear one (correlation coefficient was 0.89, which is quite good).  It is:

SF = 64 + 0.84 x PF

Usually you have the SF and want to figure out the PF, so rearranging to solve for PF (to save you all the trouble):

PF = (SF - 64) / 0.84

Since we usually care about P:F < 300 (mild ARDS), < 200 (moderate ARDS), and < 100 (severe ARDS), here are the S:F mappings for those P:Fs to make things super simple:

If P:F is 300 then S:F is 315

If P:F is 200 then S:F is 235

If P:F is 100 then S:F is148

And 150 is another P:F that is important since we often consider proning and/or paralysis under this level.  That would equate to an S:F of 190 using this formula.

Don't forget!  The SpO2 is expressed as a percentage, and FiO2 as a decimal.  So for example, for a patient with a sat of 97% on RA (21% FiO2):

97 / 0.21 = 461 would be their S:F.

Show References

Chaudhuri D, Lazarte J, Shah K, Pitre T, Pekkarinen PT, Sendagire C, Martin GS, Jung C, Laffey JG, Rochwerg B; Sequential Organ Failure Assessment (SOFA)-2 study group. Approaches to Converting Sp o2 /F io2 Ratio to Pa o2 /F io2 Ratio for Assessment of Respiratory Failure in Critically Ill Patients: A Systematic Review. Crit Care Med. 2026 Apr 1;54(4):950-959. doi: 10.1097/CCM.0000000000007018. Epub 2026 Jan 2. PMID: 41493393.



Title: Necrotizing Fasciitis on Ultrasound

Category: Ultrasound

Keywords: soft tissue; point of care ultrasound (PubMed Search)

Posted: 4/20/2026 by Alexis Salerno Rubeling, MD

Sonographic findings suggestive of necrotizing fasciitis include: 

  • Thickening of the deep fascia 
  • Diffuse thickening of the overlying fatty tissue 
  • At least a 4 mm thick fluid layer along the deep fascia 
  • Dirty Shadow if gas is present

Remember the mnemonic: STAFF (subcutaneous thickening, air, and fascial fluid) 

Show References

Castleberg E, Jenson N, Dinh VA. Diagnosis of necrotizing fascititis with bedside ultrasound: the STAFF exam. West J Emerg Med. 2014;15(1):111-3.



Title: Hidden in Plain Sight: Incidentally Detected Atrial Fibrillation on Continuous ECG Monitoring

Category: Cardiology

Keywords: Atrial Fibrillation, Incidental Finding, ECG Monitoring, Anticoagulation (PubMed Search)

Posted: 4/20/2026 by Lena Carleton, MD (Updated: 4/20/2026)

Bottom line: Routine screening for atrial fibrillation (AF) is not recommended in the emergency department (ED). However, AF is often detected incidentally on continuous ECG monitoring. When identified, clinicians should inform the patient and consider anticoagulation if indicated.

Show Additional Information

Ischemic stroke remains a major cause of morbidity and mortality, with AF implicated in at least 12% of cases. Early detection allows for stroke prevention through timely anticoagulation.

In this single-center retrospective cohort study of 65,244 adult ED patients on continuous ECG monitoring (2020–2024), AF was detected in 10.1%. Of these, 48.7% had known AF, 21.6% were diagnosed or treated during the visit, and 29.6% were discharged without diagnosis or anticoagulation (“undiagnosed AF”), representing 3% of the total cohort. This group was more likely to be women, Black or Latino, Medicaid-insured, and without a primary care physician; 58.3% of the “undiagnosed AF” group met criteria for anticoagulation.

Over a median follow-up of 238 days, stroke incidence was 2.6 per 100 person-years in the undiagnosed AF group, compared with 2.4 in known AF and 0.5 in those without AF.

These findings suggest that opportunistic detection of AF in the ED may identify high-risk patients who could benefit from earlier diagnosis and anticoagulation.

Bottom line: Routine screening for atrial fibrillation (AF) is not recommended in the emergency department (ED). However, AF is often detected incidentally on continuous ECG monitoring. When identified, clinicians should inform the patient and consider anticoagulation if indicated. Though not explicitly discussed in this article, it is worth noting that incidental findings may also carry medicolegal implications.

Show References

Bismuth E, Jin BT, Molins E, et al. Opportunistic screening for atrial fibrillation with continuous ECG monitoring in the emergency department. Ann Emerg Med. 2026;87(1):56-65. doi:10.1016/j.annemergmed.2025.06.008



Title: Obesity, trauma and ARDS

Category: Trauma

Keywords: obesity, trauma, mortality, organ failure, sepsis, ARDS (PubMed Search)

Posted: 4/18/2026 by Robert Flint, MD (Updated: 4/18/2026)

This German retrospective review of 1500 level one trauma center patients (ICU level or ISS over 9) found obesity was an independent predictor of ARDS, multisystem organ failure, and  sepsis but not pneumonia or mortality.

Show References

Erdle, B., Mangold, J., Kalbhenn, J. et al. BMI is independently associated with ARDS, sepsis and multiorgan failure after major trauma—results of a high-volume retrospective observational cohort study. Scand J Trauma Resusc Emerg Med (2026). https://doi.org/10.1186/s13049-026-01603-7



Title: Exploring Demographic Differences in Postintubation Analgesia by Racial Group, Sex, and Age

Category: Administration

Posted: 4/18/2026 by Kevin Semelrath, MD (Updated: 4/18/2026)

Multiple past studies have shown that Black and female patients tend to be prescribed fewer opioids than White and male patients. This study looked at the rates of opioid usage post RSI.

They found that while Black patients received opioids at a higher rate, they were given lower doses than white patients. Older patients were less likely to receive opioids post RSI than younger patients.  They did not find a difference in rates of opioid usage between genders, but female patients received lower doses of opioids overall.

Show Additional Information

AuBuchon K, Amaru A, Cepero T ...

Exploring Demographic Differences in Postintubation Analgesia by Racial Group, Sex, and Age

Journal of Emergency Medicine, 2025; 84, 69-81



Title: What are the signs of traumatic pancreatitis in the pediatric patient?

Category: Pediatrics

Keywords: Abdominal trauma, CT, lipase (PubMed Search)

Posted: 4/17/2026 by Jenny Guyther, MD (Updated: 4/17/2026)

Pancreatic injury in pediatric blunt abdominal trauma is rare. 

This study was a secondary analysis of the data collected by the Pediatric Emergency Care Applied Research Network (PECARN) in the Intra-abdominal Injury Study Group. Of the children who had blunt abdominal trauma, 6% had intraabdominal injuries and 1% had pancreatitis.  A patient was considered as having traumatic pancreatitis if they had 2 of the following: 1) upper abdominal tenderness, 2) serum lipase of amylase > 3 x the upper limit of normal or 3) imaging study positive for pancreatitis.

Show Additional Information

Children diagnosed with pancreatitis were more likely to report abdominal pain, vomiting, shortness of breath, thoracic trauma and handlebar injury compared to those without a diagnosis of pancreatitis.  On exam, they were more likely to be hypotensive, tachypneic, evidence of abdominal wall injury, costal tenderness, abdominal distention and abdominal tenderness.  When the PECARN prediction rule was applied to these patients, the sensitivity was 99% with a specificity of 42%.  The rule missed one patient who had traumatic pancreatitis, but this patient did not meet the definition for clinically important abdominal injury (requiring therapeutic laparotomy, embolization, blood transfusion or requiring IV fluids for > 2 days).

Show References

Marks MS, Liveris A, Blumberg SM, Reddy SH, Meltzer JA. Predicting Pancreatitis in Children With Blunt Abdominal Trauma. Pediatr Emerg Care. 2025 Jun 6. doi: 10.1097/PEC.0000000000003421. Epub ahead of print. PMID: 40476662.



Title: Can EMS safely decide which child requires a cervical collar?

Category: EMS

Keywords: MVC, c-spine injury, PECARN, rules (PubMed Search)

Posted: 4/15/2026 by Jenny Guyther, MD (Updated: 7/21/2026)

Cervical spine injuries (CSI) are uncommon in children, but when present, they are often devastating.  However, the application of a cervical collar in children is not benign and adverse effects include neck pain and discomfort and the downward tunnel vision it may create at the hospital leading to unnecessary testing.  Recently, the PECARN group published a set of criteria to determine who requires imaging of the cervical spine in the emergency department.  A planned subset of this initial study was to collect the impressions of EMS as they pertained to the 9 criteria to determine if these criteria could safely be used by EMS.  The patients who were brought in by EMS with the potential for cervical spine injury, who were evaluated by the trauma team and/or had cervical imaging AND had electronic case reports filled out by EMS were included in the final analysis.  Only 57% of the patients possible could be included based on the number of electronic case reports that were filled out.

Show Additional Information

Overall, when the criteria were applied to the EMS patients based on the EMS assessment, the PECARN CSI had a sensitivity of 88.5%, a specificity of 63.1%, a PPV of 3.7% and a NPV of 99.7%.

Of 122 patients, 14 patients who did have CSI were not detected.  Further analysis of these missed patients showed that 11 of the patients did have one of the 9 criteria present which was documented by the ED but not by EMS.  Only one of the 14 missed patients required operative intervention.  12/14 of these patients were from motor vehicle collisions.

The study criteria did perform better in the ED setting compared to the EMS setting.  Further research will need to examine if these clinical criteria can be applied to the field or if they should be modified to increase the specificity.  

The 9 criteria and a brief description of the original study can be found at: https://pecarn.org/pecarn_news/clinical-decision-rule-cervical-spine/

Show References

Browne LR, Ward CE, Harding M, Cook LJ, Adelgais KM, Ahmad FA, Burger R, Chaudhari PP, Corwin DJ, Glomb NW, Kuppermann N, Lee LK, Leonard JR, Owusu-Ansah S, Riney LC, Rogers AJ, Rubalcava DM, Sapien RE, Szadkowski MA, Tzimenatos L, Yen K, Leonard JC. Performance of the PECARN cervical spine injury prediction rule based on EMS clinician observations. J Trauma Acute Care Surg. 2025 Aug 21. doi: 10.1097/TA.0000000000004772. Epub ahead of print. PMID: 40836370.



Title: More Protein or More Water?: Albumin vs. Crystalloid in Septic Shock

Category: Critical Care

Keywords: albumin, sepsis, septic shock, crystalloid, resuscitation (PubMed Search)

Posted: 4/14/2026 by Zach Wynne, MD

Summary:

The recent ARISS (Albumin Resuscitation in Septic Shock) trial showed no difference in 90-day mortality or other secondary outcomes, similar to other trials comparing albumin and crystalloid. Notably however, the trial did not meet its predetermined enrollment requirement of patients (in the setting of the COVID-19 pandemic) and had a large portion of its intervention group failing to meet goal serum albumin level. 

The Bottom Line:

There remains no evidence-based mortality benefit of albumin over crystalloid in patients with septic shock that do not have additional indications for albumin (such as hepatorenal syndrome). Crystalloid resuscitation remains a staple of appropriate and cost-effective care in septic shock. Albumin can be considered on a case-by-case basis after standard crystalloid resuscitation in this clinical setting.

Show Additional Information

Background:

What is the ideal fluid for resuscitation in septic shock? Crystalloids or colloids, such as albumin?

Many trials have sought to prove albumin would be beneficial in septic shock. Some data has suggested an immune modulatory role of albumin. Additionally, albumin is thought to help maintain serum oncotic pressure to prevent further capillary leak in vasodilatory shock. A summary of some trials before ARISS are summarized below:

  • SAFE trial (2003) compared 4% albumin and normal saline in the ICU setting and found no mortality difference at 28 days except a higher mortality rate in subgroup of patients with TBI. 
  • CRISTAL trial (2013) looked at all crystalloids vs all colloids in septic shock in the ICU setting and found no difference in 28 day mortality. There was a non-statistically significant trend showing decreasing 90 day mortality with colloids.
  • ALBIOS trial (2014) compared 20% albumin (targeting albumin level of >3g/dL) to crystalloids in the ICU setting. There was no difference in 28 and 90 day mortality but a non-statistically significant trend showing early albumin having decreased mortality.
  • ICARUS-ED trial (2025) was a pilot RCT in the ED setting, comparing single 400 mL 20% albumin vs. crystalloids alone. There was no difference in SBP at 24 hours or mortality at 72 hours but a trend towards lower fluid volume and vasopressor use.

With this background, researchers in Germany sought to further evaluate albumin's role in septic shock resuscitation.

ARISS (Albumin Resuscitation in Septic Shock) Trial - Feb 2026

Patients: Adults admitted to ICUs in Germany from 10/2019 to 5/2022 that had probable or definitive evidence of infection for septic shock,  required vasopressors for at least one hour (MAP > 65 mmHg)?, had a lactate less than 18 mg/dL (2.0 mmol/L)?, and were enrolled within 24 hours of onset of septic shock. Exclusion criteria included patients that had a disease process that albumin is particularly harmful or advantageous (CHF, TBI, hepatorenal)?, pregnancy/lactation, alternative etiology of shock, and end of life care.

Intervention: All patients in intervention group received a 60-g loading dose of 20% albumin over 2-3 hours within 6-24 hrs after diagnosis of septic shock. Remainder of albumin administration was done by a resuscitation scheme to target an albumin greater than 3 g/dL while they remained alive and in the ICU.

Control: All patients in control group received crystalloid resuscitation but could receive albumin in certain situations deemed necessary (such as albumin < 1.5 g/dL).

Outcome: Primary outcome was 90-day all-cause mortality. Secondary outcomes included 28-day and 60-day mortality, ICU and hospital mortality, SOFA score change, ICU and hospital length of stay, ventilator-free and vasopressor-free days, and occurrence of adverse events.

Results: 440 patients were randomized, with 419 included in analysis. Albumin was administered in the intervention group for a median of 5 days. 15 patients received the full 28-day limit of protocol treatment with albumin. More than 50% of patients in the intervention group failed to achieve the target albumin level of greater than 3 g/dL. 90-day mortality by intention to treat analysis was 43.4% in the albumin group versus 45.9% in the control group (RR of 0.94 [95% CI, 0.76-1.17]) with no differences in subgroup analyzes. No secondary outcomes showed a statistically significant difference. There was no statistically significant difference in adverse events between groups.

Internal Validity: Enrollment did not meet need based on power calculation (estimated 1662 patients by their power calculation for a relative risk reduction of 15%. Factors affecting this included COVID-19 pandemic and a high exclusion rate for the trial enrollment of 72%. Additionally, many patients in the control group received albumin. The researchers additionally did a per-protocol analysis which also showed no statistically significant difference.

Ending Thoughts: This was a well designed trial combining elements of trials comparing albumin to crystalloids previously and using albumin to reach a defined target, similar to the ALBIOS trial. However, the lack of enrollment and not meeting their predetermined power calculation likely contributed to the results found in this trial. The trial leaves unanswered questions about albumin's role in septic shock, particularly with earlier timing and a clear concentration target.

Show References

  1. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004 May 27;350(22):2247-56. doi: 10.1056/NEJMoa040232. PMID: 15163774.
  2. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, Preiser JC, Outin H, Troché G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec'h C, Cousson J, Thibault L, Chevret S; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013 Nov 6;310(17):1809-17. doi: 10.1001/jama.2013.280502. Erratum in: JAMA. 2013 Mar 12;311(10):1071. Régnier, Jean [corrected to Reignier, Jean]; Cle'h, Christophe [corrected to Clec'h, Christophe]. PMID: 24108515.
  3. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L; ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014 Apr 10;370(15):1412-21. doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18. PMID: 24635772.
  4. Williams JM, Greenslade JH, Hills AZ, Ray MT. Intervention With Concentrated Albumin for Undifferentiated Sepsis in the Emergency Department (ICARUS-ED): A Pilot Randomized Controlled Trial. Ann Emerg Med. 2025 Jul;86(1):59-69. doi: 10.1016/j.annemergmed.2024.12.016. Epub 2025 Jan 23. PMID: 39846907.
  5. Sakr Y, Nierhaus A, Schumacher U, Utzolino S, Jaschinski U, Petros S, Fichtner F, Eimer C, Putensen C, Tanev I, Kreienbühl L, Kluge S, Kousoulas L, Kuhn SO, Jarczak D, Quintel M, Bauer M; SepNet Critical Care Trials Group and Albumin Replacement Therapy in Septic Shock (ARISS) investigators. Albumin Replacement Therapy in Septic Shock: A Randomized Clinical Trial. JAMA Netw Open. 2026 Feb 2;9(2):e2559297. doi: 10.1001/jamanetworkopen.2025.59297. PMID: 41712212; PMCID: PMC12921518.


Title: Can US be effectively used in the prehospital setting?

Category: EMS

Keywords: prehospital, EMS, ultrasound (PubMed Search)

Posted: 4/12/2026 by Robert Flint, MD (Updated: 4/12/2026)

This German retrospective study compared the prehospital use of ultrasound by trained paramedics and compared their findings to in-hospital diagnosis and image results. The authors found: 

“Diagnostic accuracy, defined as the concordance between prehospital POCUS-based working diagnoses and final in-hospital diagnoses, was particularly strong for lung ultrasound (pneumothorax, pulmonary edema, pneumonia and pleural effusion; sensitivity 91.7%, specificity 100%) and eFAST (sensitivity 100%, specificity 96.5%), while for the abdominal ultrasound examinations, the specificity was 70% and sensitivity was 71.43%.”

This study sets the stage for future prospective work looking at prehospital US use by paramedics.

Show References

Boehm, A., Bexten, T., Stanley, M. et al. Feasibility and diagnostic accuracy of paramedic-performed prehospital point-of-care ultrasound: a retrospective observational study. Scand J Trauma Resusc Emerg Med (2026). https://doi.org/10.1186/s13049-026-01595-4



Title: Does my child have a concussion?

Category: Orthopedics

Posted: 4/11/2026 by Brian Corwell, MD

What elements of the history are most helpful for diagnosing a concussion?

An estimated 1.1 million to 1.9 million pediatric concussions occur annually in the US.

Show Additional Information

Does my child have a concussion?

OBJECTIVE: To determine the accuracy of clinical history for identifying concussion in children and adolescents.

While most children recover within 4 weeks, approximately 30% experience persistent symptoms beyond 28 days. 

Early evaluation and timely management are associated with improved recovery—athletes who immediately reported their injury experienced almost five and half fewer days of symptoms compared to those who delayed reporting. 

Key Diagnostic Findings

The review identified the most diagnostically useful symptoms (by likelihood ratio):

Finding Likelihood Ratio (LR+) Specificity
Mental fog 11.8–12.0 0.96
Noise sensitivity 6.9 0.94
Nausea 6.7 0.93
Light sensitivity 6.4 0.93
Headache 3.1 0.74

The ABSENCE of headache was the only finding that substantially reduced the likelihood of concussion (LR, 0.20; sensitivity, 0.86)

Show References

Shah SN, Chizuk HM, Fong H, Hannon M, Mannix RC. Does This Child Have a Concussion? The Rational Clinical Examination Systematic Review. JAMA. 

Published online April 06, 2026.



Title: Best Practices for the <12 month old's airway

Category: Pediatrics

Keywords: pediatrics, airway, intubation, infant, neonate (PubMed Search)

Posted: 4/10/2026 by Kat Stephanos, MD (Updated: 7/21/2026)

BOTTOM LINE:

  • Use of VL and cuffed ETTs are appropriate for all ages
  • Hyperangulated blades, LMAs and scopes should be available for rescue
  • Apneic oxygenation is useful in neonates. 

A 2024 meta analysis from the European Society of Anaesthesiology and Intensive Care and British Journal of Anaesthesia worked to develop joint guidelines for best practices for intubation of neonates and infants. 

While this guide is focused primarily on anesthesia and operative care, several of the recommendations have practical application to the EM and ICU as well. 

They focused on general guidance including ensuring appropriate anesthesia and analgesia during intubation. But also discussed that videolaryngoscopy with standard blades is the most appropriate first line for all intubations in this age group. It allows for appropriate visualization either directly or by video and for learners allows instructors to observe as well. 

When there are difficulties with intubation, hyperangulated blades have very high success rates, but LMA and video assisted intubation with a fiberoptic scope are also appropriate next steps for securing an airway. 

When intubating, uncuffed endotracheal tubes are acceptable in all infants though cuffed are also safe in infants over 3kg in weight.

Finally, while apneic oxygenation is regularly used in adults, it is also recommended in the neonatal period to avoid hypoxia.

Show References

Disma N, Asai T, Cools E, Cronin A, Engelhardt T, Fiadjoe J, Fuchs A, Garcia-Marcinkiewicz A, Habre W, Heath C, Johansen M, Kaufmann J, Kleine-Brueggeney M, Kovatsis PG, Kranke P, Lusardi AC, Matava C, Peyton J, Riva T, Romero CS, von Ungern-Sternberg B, Veyckemans F, Afshari A; and airway guidelines groups of the European Society of Anaesthesiology and Intensive Care (ESAIC) and the British Journal of Anaesthesia (BJA). Airway management in neonates and infants: European Society of Anaesthesiology and Intensive Care and British Journal of Anaesthesia joint guidelines. Eur J Anaesthesiol. 2024 Jan 1;41(1):3-23.



Title: Tenecteplase Strikes Out for CRAO

Category: Pharmacology & Therapeutics

Keywords: central retinal artery occlusion, tenecteplase, thrombolytic (PubMed Search)

Posted: 4/9/2026 by Alicia Pycraft (Updated: 4/9/2026)

TenCRAOS was a phase 3 randomized, multi-center, double blind, double dummy, placebo-controlled trial in 78 patients that showed no significant difference in visual outcomes at 30 days for IV tenecteplase 0.25 mg/kg compared to aspirin 300 mg alone within 4.5 hours of central retinal artery occlusion (CRAO) symptom onset. Tenecteplase was associated with more serious adverse events, one of which was a fatal intracerebral hemorrhage.  

Bottom line: Although tenecteplase has theoretical advantages in CRAO, the results of this trial do not support routine use.

Show Additional Information

Study design:

  • Phase 3 randomized, multi-center, double blind, double dummy, placebo-controlled trial
  • Included patients with CRAO diagnosed with best corrected visual acuity (BCVA) of 1.0 log-MAR or greater in the affected eye and were able to receive treatment within 4.5 hours
  • Interventions: Tenecteplase 0.25 mg/kg (max of 25 mg) + oral placebo vs. oral aspirin 300 mg + IV placebo (randomized 1:1)
  • Primary endpoint: BCVA of 0.7 log-MAR or lower in the affected eye at 30 days after treatment (Considered a clinically meaningful improvement in visual acuity on the Early Treatment Diabetic Retinopathy Study Chart)

Results:

  • 78 patients included in final analysis (40 in tenecteplase group and 38 in aspirin group)
  • No significant difference in the number of patients with BCVA of 0.7 log-MAR or lower for tenecteplase compared to aspirin (20% vs 24%, risk difference -0.04 (-0.22 to 0.15). Result was consistent across all visual efficacy endpoints and among a subgroup of patients treated within 3 hours of symptom onset.
  • Adverse events occurred in 48% of patients in the tenecteplase group and 34% in the aspirin group.
    • More serious adverse events in the tenecteplase group (10 events among 8 patients vs. 4 events among 4 patients in the aspirin group)
    • One serious adverse event attributed to tenecteplase was fatal. Event involved ongoing cerebral ischemia that was not apparent on head CT or clinically. Multiple intracerebral hemorrhages caused by reperfusion of damaged brain tissue developed after tenecteplase administration.

Show References

Ryan SJ, Jørstad ØK, Skjelland M, Pesonen M, Simonsen CZ, Bek T et al.  A randomized trial of tenecteplase in central retinal artery occlusion. N Engl J Med. 2026. 394(5): 442-450.



Title: Gender affects trauma triage and care

Category: Trauma

Keywords: trauma, treatment disparity, gender (PubMed Search)

Posted: 4/8/2026 by Robert Flint, MD (Updated: 4/8/2026)

This systematic literature review looking at gender differences in trauma care reveals:

  1. Women were older with more low-energy trauma than men. 
  2. Women were more likely to suffer from pelvic and spinal cord injuries. 
  3. Women were more likely to be under-triaged and under-treated.
  4. Sex/gender-based differences in mortality were inconsistent across studies. 
  5. Adjusted mortality appeared similar between women and men

Show References

Ghika-Nanchen, A., Marzorati, L., Merra, A. et al. Sex and gender bias in major trauma care: a scoping review. Scand J Trauma Resusc Emerg Med (2026). https://doi.org/10.1186/s13049-026-01596-3



Previous  |  1 |  2 |  3 |  4 |  5 |  6 |  7 |  8 |  9 |  ... |  236 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map